Moderator: Julie Miller, Editor in Chief, Behavioral Healthcare Executive and Addiction Professional

CE Certified By: AAFP,ACPE,GA POST

This session is designed as an opportunity for the U.S. Drug Enforcement Administration (DEA) to share developments and guidance to pharmacists to inform their efforts to respond to the nation’s Rx drug abuse and heroin epidemics. The presenter will describe the nation’s current opioid abuse and diversion trends, the basic responsibilities for pharmacists under federal law and regulations, the checks and balances of the Controlled Substances Act, the legal obligations of DEA registrants, and DEA’s response to the current opioid epidemic. He also will address new regulations, such as the Comprehensive Addiction and Recovery Act. The presentation will demonstrate how the current public health epidemic has impacted society and provide tips for pharmacists to respond, such as measures for preventing Rx drug misuse and securing pharmacies from drug theft and robberies.

UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Explain the corresponding responsibility of pharmacists.
- Describe “red flags” that may indicate pharmaceutical diversion.
- Identify Effective Controls and Preventative Measures against pharmacy diversion.